Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/0321 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AORTArtivion Inc
2024/06/0321 : 23Alliance NewsAlliance NewsIN BRIEF: Aviva Non-Exec Cheryl Agius buys GBP72,000 in sharesLSE:AV.Aviva Plc
2024/06/0321 : 23GlobeNewswire Inc.LCS Announces 2024 Chef of the Year Finalists
2024/06/0321 : 23PR Newswire (US)The Seasons Games - An immersive experience at the Théâtre du Lido des Champs-Elysées in Paris
2024/06/0321 : 23PR Newswire (Canada)The Seasons Games - An immersive experience at the Théâtre du Lido des Champs-Elysées in Paris
2024/06/0321 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AORTArtivion Inc
2024/06/0321 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBOTMicrobot Medical Inc
2024/06/0321 : 20GlobeNewswire Inc.Form 8.3 - Irish Residential Properties REIT plc
2024/06/0321 : 20GlobeNewswire Inc.Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical TrialNASDAQ:MBOTMicrobot Medical Inc
2024/06/0321 : 20PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - CZOTSXV:CZOCeapro Inc
2024/06/0321 : 19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:HNDAFHonda Motor Co Ltd (PK)
2024/06/0321 : 18Edgar (US Regulatory)Form 8-K - Current reportNYSE:RCUSArcus Biosciences Inc
2024/06/0321 : 18PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - CZOTSXV:CZOCeapro Inc
2024/06/0321 : 17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FTAIPFTAI Aviation Ltd
2024/06/0321 : 17GlobeNewswire Inc.Report on transactions of executives and related parties in ROCKWOOL A/S sharesTG:R90Rockwool AS
2024/06/0321 : 17Alliance NewsAlliance NewsIN BRIEF: Hostmore says earnings up as TGI Fridays merger progressesLSE:MOREHostmore Plc
2024/06/0321 : 17Alliance NewsAlliance NewsIN BRIEF: Hostmore says earnings up as TGI Fridays merger progressesLSE:MOREHostmore Plc
2024/06/0321 : 17PR Newswire (US)Hi-Tech Pharmaceuticals: Increases Capacity on Precision Protein™ Hydrolyzed Whey
2024/06/0321 : 16Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:CMCanadian Imperial Bank of Commerce
2024/06/0321 : 15Edgar (US Regulatory)Form 8-K - Current reportNYSE:OHIOmega Healthcare Investors Inc
2024/06/0321 : 15Business WireThermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024
2024/06/0321 : 15Business WireNorthCoast Asset Management, a Business Line of Connectus Wealth Advisers, Joins Kovitz
2024/06/0321 : 15Business WireBridge Investment Group Announces Hiring of Alison Brown as President of Bridge Property Management and Deputy Chief Investment Officer for Bridge Workforce and Affordable Housing StrategyNYSE:BRDGBridge Investment Group Holdings Inc
2024/06/0321 : 15Business WireFocus Announces That Five U.S. Business Lines of Connectus Wealth Advisers Have Joined The Colony Group
2024/06/0321 : 15Business WireCoya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in NeurologyNASDAQ:COYACoya Therapeutics Inc
2024/06/0321 : 15Business WireEquitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt SecuritiesNYSE:EQHEquitable Holdings Inc
2024/06/0321 : 15GlobeNewswire Inc.Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical TrialNASDAQ:AMIXAutonomix Medical Inc
2024/06/0321 : 15PR Newswire (US)First Fully Electronic F-TIIE Swap Trade Executed on the Bloomberg SEF
2024/06/0321 : 14Alliance NewsAlliance NewsIN BRIEF: GetBusy CEO Daniel Rabie buys GBP240,000 in sharesLSE:GETBGetbusy Plc
2024/06/0321 : 14GlobeNewswire Inc.AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim